| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |